Colin - Broom
He joined Nabriva Therapeutics in August 2014. He has a bachelor of science degree in pharmacology from University College, London and a bachelor of medicine and surgery degree from St. George’s Hospital Medical School, London. He is a Member of the UK Royal College of Physicians and a Fellow of the Faculty of Pharmaceutical Medicine. Over the past 30 years Colin has been involved in all stages of drug development and commercialization. Most recently, he served as Chief Scientific Officer at ViroPharma, Inc., (now Shire). Previous positions have included a range of leadership positions with Amgen, Hoechst Marion Roussel (now Sanofi), SmithKline Beecham and Glaxo (now GlaxoSmithKline).